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In human cytomegalovirus (HCMV) infection, both of the major immediate-early proteins IE1(IE68, UL123) and IE2(IE86,
UL122) target to PML protein-associated nuclear bodies known as PODs or ND10 at very early times after infection. IE1
causes a redistribution of both PML and IE1 from the PODs into a nuclear diffuse form, whereas IE2 initially localizes
adjacent to PODs but later associates with viral DNA replication compartments. The peripheries of PODs are also believed
to be sites for initiation of both viral IE transcription and DNA replication. However, because IE1 is nonessential at high
multiplicity of infection (m.o.i.) in HF cells, the exact role of these processes in viral infection has been enigmatic. Therefore,
we investigated the effects of overexpression of PML in the presence or absence of IE1 on the intranuclear distribution of
IE2 and formation of viral DNA replication compartments, as well as on the levels of delayed-early and late viral transcription
and protein accumulation. Infection with wild-type HCMV(Towne) and the IE1-deleted derivative HCMV(CR208), which fails
to disrupt PODs, was compared in a pair of related astrocytoma/glioblastoma cell lines, the U373-Neo control and a variant
U373-PML that constitutively overexpresses PML(560) in much larger than normal PODs. IFA studies on the localization
patterns for IE1, IE2, and PML showed that, although the numbers of IE2-positive cells were not significantly reduced in either
the wild-type virus-infected U373-PML cell line or in DIE1-infected control cells, POD disruption by IE1 in wild-type virus
infection was delayed by up to 6 h in U373-PML cells compared to control cells. Furthermore, there was considerable
enhancement of IE2 colocalization with PODs in DIE1-infected U373-PML cells. Formation of viral DNA replication compart-
ments in the U373-PML cell line was also greatly delayed, measured at fivefold lower after wild-type virus infection and
12-fold lower after infection with DIE1 than in the control cell line at 48 h at an m.o.i. of 1.0. The levels of representative early
and late viral proteins detected by Western blotting were suppressed by fivefold and 22-fold at 24 and 72 h, respectively, in
the U373-PML cell line, even with high m.o.i. wild-type HCMV infection. Decreased viral protein levels also occurred when
control cells were infected with the DIE1 virus and these two effects were additive in the U373-PML cell line. Similarly, when
U373-PML cells were infected with recombinant HCMV expressing an extragenic luciferase reporter gene under the control
of viral early (Pol) or late (pp28) promoters, their transcriptional activation was reduced up to fivefold at both high and low
m.o.i. compared to that of the control cells. Overall, these results suggest that POD disruption by IE1 and subsequent
redistribution of both PML and IE1 at very early times after infection may play an important role in the efficient utilization of
cellular transcription and replication machinery by HCMV and contribute to rapid progression of the HCMV lytic cycle.
© 2000 Academic Press
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Promyelocytic leukemia protein (PML)-associated nu-
clear bodies known as PML oncogenic domains (PODs) or
nuclear domain 10 (ND10) are matrix-associated nuclear
structures (Ascoli and Maul, 1991; Dyck et al., 1994) in
which the PML protein surrounds an electron-dense core
(Koken et al., 1994; Weis, 1994). The PODs are dynamic
structures that form between 5 and 20 distinct small punc-
tate bodies throughout the nucleus in most cell types (As-
coli and Maul, 1991), but disappear during mitosis (Ascoli
and Maul, 1991; Doucas and Evans, 1996; Koken et al.,
1995) and are induced by interferon treatment (Chelbi-Alix
et al., 1995; Lavau et al., 1995) or stress (Maul et al., 1995).
1 (
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39Although several other cellular proteins including SP100
are known to be present in PODs, their roles have not been
well defined as yet (for review, see Maul, 1998). PML, the
most extensively studied POD protein, was first identified
as a part of a fusion protein with the alpha retinoic acid
receptor that resulted from the t(15:17) translocation in
acute promyelocytic leukemia (APL) (de The et al., 1991;
Goddard et al., 1991; Kakizuka et al., 1991; Kastner et al.,
992). The punctate distribution of PML in APL cells is
hanged into a microspeckled pattern, but the normal dis-
ribution pattern of PML can be restored by treatment with
etinoic acid, which correlates with regaining both growth
ontrol and the ability to differentiate (Dyck et al., 1994;
rignanai et al., 1993; Koken et al., 1994). Several other
tudies suggest that PML functions as a growth suppressor
Koken et al., 1995; Le et al., 1996; Liu et al., 1995; Mu et al.,
994; Wang et al., 1998a).
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40 AHN AND HAYWARDThe integrity of PODs is also affected by infection by
DNA viruses, including adenovirus (Carvalho et al., 1995;
Doucas et al., 1996; Puvion-Dutilleul et al., 1995), herpes
simplex virus-1 (HSV-1) (Everett and Maul, 1994; Maul
and Everett, 1994, Maul et al., 1993), and human cyto-
megalovirus (HCMV) (Ahn and Hayward, 1997; Kelly et
al., 1995; Korioth et al., 1996), leading to degradation or a
dispersed relocation of POD proteins at early times after
infection. The viral regulatory proteins responsible for
the disruption of PODs are E4-ORF3 in adenovirus (Car-
valho et al., 1995; Doucas et al., 1996), IE110 (ICP0) in
HSV-1 (Everett and Maul, 1994; Maul and Everett, 1994,
Maul et al., 1993), and IE1 in HCMV (Ahn and Hayward,
1997; Korioth et al., 1996; Wilkinson et al., 1998). We have
shown that both IE1(IE68, UL123) and IE2(IE86, UL122),
the major immediate-early nuclear proteins of HCMV,
initially target to PODs at very early times after infection
(Ahn and Hayward, 1997) and that IE2 is stably retained
at punctate sites adjacent to the PODs before becoming
associated with viral DNA replication compartments
(Ahn et al., 1999). However, the colocalization between
IE1 and PML is transient. Within 2 to 3 h both proteins are
subsequently redistributed as a uniform nuclear diffuse
pattern (Ahn and Hayward, 1997). Studies on the mech-
anism of the disruption of PODs during HCMV infection
have suggested that a direct interaction of IE1 with the
N-terminal RING finger domain of PML appears to inhibit
oligomerization or protein–protein complex formation by
PML, leading to displacement of both PML and IE1 into
the nucleoplasm (Ahn et al., 1998). In contrast, the dis-
uption of PODs in HSV-1 infection correlates with IE110-
nd proteasome-dependent degradation of several
UMO-1-modified isoforms of PML (Everett et al., 1998).
The PODs may be important in viral infection because
hey are closely associated with sites for initiation of viral
ranscription and DNA replication. Soon after infection,
he viral genomes of adenovirus, HSV-1, and HCMV are
referentially deposited at the periphery of PODs and
mmediate-early transcripts of HCMV are detected near
he PODs (Ishov and Maul, 1996; Ishov et al., 1997; Maul
t al., 1996). During infection, replication compartments
ave also been shown to form at sites adjacent to PODs
or both HSV-1 (Ishov and Maul, 1996; Lukonis and
eller, 1997) and HCMV infections (Ahn et al., 1999).
owever, the advantage of POD disruption for virus in-
ection is not understood as yet. During permissive lytic
CMV infection, viral genes are transcribed in a three-
tep sequential fashion (immediate-early [IE], early, and
ate), in which both the IE and virion factors are required
or the subsequent efficient induction of the early and
ate genes (for review, see Mocarski, 1996). Therefore,
e have examined the levels of viral gene expression at
E, early, and late stages after infection with either the
ild-type or an IE1-defective mutant virus. The studies
Rere carried out in a pair of Neo U373 astrocytoma/
lioblastoma cell lines, one of which constitutively over-
b
cxpresses a 560-aa isoform of PML. In other studies, we
ave found that HCMV(Towne) infection in U373 cells is
omewhat slower and more sensitive to m.o.i. than in HF
ells and that U373-NeoR cell lines constitutively ex-
ressing IE1 are converted from semipermissive to fully
ermissive cell lines with regard to much higher yields of
rogeny virions and formation of plaques by wild-type
CMV(Towne) (Burns, W. H. et al., in preparation). Here,
e demonstrate that the disruption of PODs in the U373-
ML cell line is severely delayed during wild-type HCM-
(Towne) infection compared to that in the parental cell
ine. Furthermore, all subsequent stages of viral IE, de-
ayed-early (DE), and late gene expression, as well as
ormation of viral DNA replication compartments (R.C.),
re suppressed. These effects were further enhanced by
nfection in the absence of IE1, and included a phenotype
f greatly increased colocalization of IE2 with PODs.
RESULTS
eneration of a stable U373 cell line overexpressing
ML
During HCMV infection in fully permissive HF cells, the
cidic regulatory protein IE1 is responsible for the rapid
edistribution of PML from the punctate PODs into a
uclear diffuse form within the first few hours after in-
ection (Ahn and Hayward, 1997; Korioth et al., 1996;
ilkinson et al., 1998). This process also occurs effi-
iently but apparently without any effects on cell survival,
n U373-MG astrocytoma/glioblastoma cell lines that
onstitutively express the HCMV IE1 protein (Ahn and
ayward, 1997). Wild-type HCMV(Towne) does not nor-
ally form plaques on the parent U373 cell monolayers,
ut gives low yields of infectious progeny virions over a
elatively slow time course in a highly m.o.i.-dependent
ashion (Duclos et al., 1989). However, in the U373-IE1
ell lines HCMV(Towne) infection can become fully per-
issive (Burns, W. H. et al., in preparation). To study the
ole of POD disruption by IE1 in viral infection, we gen-
rated another U373-derived cell line that constitutively
verexpresses one of the several isoforms of PML.
onolayer cultures of U373 cells were transfected with
ither pSV2-Neo or pSV2-Neo plus pCMX-PML encoding
he human PML(560) protein (Kakizuka et al., 1991). Neo-
esistant colonies were recovered and analyzed for the
verexpression of PML by indirect immunofluorescence
ssay (IFA) using antipeptide polyclonal antibody (PAb)
gainst the C-terminus of PML. Two of 20 clones ana-
yzed displayed a larger-than-usual overexpressed gran-
lar pattern when stained by IFA for PML compared to
he normal smaller punctate pattern of the endogenous
ML in the control cell line (U373-Neo). The clone with
arger PODs (U373-PMLcl-12) was chosen as the most
ppropriate for these studies (Fig. 1). The relatively few
ut very large PODs found in the U373-PML cell line
losely resembled the pattern obtained in Vero cells
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41ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONtransiently transfected with plasmid pCMX-PML (Ahn et
al., 1998).
The level of expression of the intact exogenous
ML(560) protein in U373-PML cells was examined by
estern blot analysis (Fig. 2A), which confirmed the
resence of an abundant band of 68 kDa together with a
arger form migrating at about 90 kDa (indicated as
ML*). This form is probably PML(560) that is covalently
onjugated with small ubiquitin-like modifier-1 known as
UMO-1, PIC1, or Sentrin (Kaminati et al., 1998; Muller et
al., 1998; Sternsdorf et al., 1997). A broad smeared-band
attern of the exogenous PML and a single higher-
olecular-weight SUMO-1-modified exogenous PML
and were also described in stably transfected Chinese
amster ovary (CHO) cells receiving the same PML(560)
Duprez et al., 1999). Although PML has been reported to
ave growth-suppressive activity in transfected cells and
ell lines (Chelbi-Alix et al., 1998; Le et al., 1996; Mu et al.,
994), the comparison of growth profiles between U373-
ML and U373-Neo did not show any significant differ-
nce over a 7-day period (Fig. 2B). Similarly, although
ML-induced G1 arrest and apoptosis have been sug-
ested previously in other cell types (Le et al., 1998; Mu
t al., 1997; Quignon et al., 1998; Wang et al., 1998b), we
did not detect any significant differences in either the
proportion of G1 and S-phase cells after release from
exogenous G0 arrest with serum starvation (Fig. 2C), or
in constitutive levels of apoptotic cells between the
U373-PML and U373-Neo cell lines (Fig. 2D).
The size and number of PML-containing PODs is
known to change significantly during cell cycle progres-
sion (Doucas and Evans, 1996; Koken et al., 1995), with
an almost complete loss of the PODs occurring in cells
undergoing mitosis (Ascoli and Maul, 1991). In addition,
residual PML in mitotic cells often forms a small number
FIG. 1. Overexpression of PML(560) in large granular PODs in the U3
parental control cell line (U373-Neo) were compared by IFA after fixin
anti-PML PAb antiserum plus rhodamine-coupled donkey anti-rabbit Ig
nucleus but, as with the parent cells, an occasional granule occurs inof irregular aggregates and the SUMOylated forms are
reported to be absent during mitosis (Everett et al., 1999).Therefore, we investigated whether the cell-cycle-related
changes in the PML localization pattern occurred nor-
mally in the overexpressing U373-PML cells. Double-
label IFA detection of PML and DAPI staining of the
cellular DNA showed that most of the PML signals in
both U373-Neo (Figs. 3a and 3e) and U373-PML (Figs. 3c
and 3g) cell lines were localized to punctate bodies
within the nucleus, although most U373-PML cells also
contained one or more large punctate bodies in the
cytoplasm. In cells undergoing mitosis as detected by
DAPI staining of metaphase chromosome patterns
(methanol fixation procedure), most of the punctate PML
signals in both cell lines disappeared (Figs. 3e–3h, ar-
rows). The SUMOylated forms of PML(560) were also lost
in metaphase U373-PML cells harvested after Nocoda-
zole treatment, although alternatively modified forms
also appeared (data not shown). Therefore, these results
demonstrated that despite overexpression of the exoge-
nous PML protein, the functional metaphase-dependent
dissolution of even the largest granular PODs was still
regulated relatively normally during cell cycle progres-
sion.
PML displacement during wild-type HCMV infection is
delayed in the U373-PML cell line
In HF cells infected with wild-type HCMV(Towne), PML
was essentially completely displaced from the PODs in
almost all infected cells before 6 h even at the lowest
m.o.i. (0.5) tested (Ahn and Hayward, 1997). To study the
effect of IE1 on distribution of overexpressed PML(560),
both the U373-Neo and U373-PML cell lines were in-
fected with HCMV(Towne) at an m.o.i. of 0.5 and the
location of both the IE1 and IE2 proteins as well as PML
were investigated by IFA (Figs. 4A and 4B). A quantitative
L cell line. A U373 cell clone overexpressing PML (U373-PML) and its
e paraformaldehyde/Triton X-100 procedure and staining with rabbit
ndary antibodies. Most of the overexpressed PML granules are in the
toplasm.73-PM
g by thcomparison of the fraction of cells showing different PML
staining patterns (ND, nuclear diffuse; P, punctate; ND/P,
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42 AHN AND HAYWARDa mixture of ND and P patterns) among IE1-positive cells
is presented in Fig. 4C. Without virus infection, 98% of
both the U373-Neo and the U737-PML cells showed the
punctate PML staining patterns (data not shown). As
expected, at 4 h after infection, PML was redistributed
into a nuclear diffuse form together with IE1 in at least
95% of the virus-infected U373-Neo cells (Fig. 4A, a and
b; Fig. 4C), In contrast, PML was still associated with IE1
in punctate PODs in 80% of U373-PML cells at the same
time point (4 h) after infection (Fig. 4A, c and d; Fig. 4C).
However, in almost all U373-PML cells PML was even-
tually displaced together with IE1 at later time points,
with 40% of cells by 9 h and only 5% cells by 22 h still
FIG. 2. Confirmation of exogenous PML(560) protein expression and
normal growth profiles in U373-PML cells. (A) Samples (30 mg) of
extracts from control U373-Neo cells and U373-PML cells were sepa-
rated on SDS–8% PAGE and the PML protein bands were detected by
Western blot analysis using anti-PML(C)-specific rabbit PAb. A novel
strong PML band corresponding to the expected size (68 kDa) of
overexpressed exogenous PML(560), as well as its presumed 80-kDa
SUMO-1-modified isoform (PML*), was detected only in U373-PML
cells. (B) U373-Neo and U373-PML cells were seeded into 60-mm
dishes at a density of 2 3 105 cell per well. After culture for 1, 3, 5, and
days, cells were collected by trypsin treatment and the mean total cell
ounts measured in duplicate samples. (C) U373-Neo and U373-PML
ells synchronized at G0 stage by serum starvation were released by
eplating with normal fresh medium. At the indicated time points, cells
ere pulse-labeled with BrdU before fixation in methanol and the
opulation of S-phase cells was counted by labeling with BrdU-specific
Ab. (D) Externalization of phospholipid phosphatidylserine (PS) by
ells undergoing apoptosis was assayed by flow cytometry after dou-
le-labeling with Annexin V-FITC and propidium iodide.showing the POD-associated pattern (Fig. 4A, e and f;
Fig. 4C).Similarly, we investigated the IE2 localization patterns
in the U373-Neo and U373-PML cell lines. In the parent
cell line, IE2 showed a typical nuclear punctate pattern
with a weak nuclear diffuse background at 6 h, although
PML was already totally displaced by IE1 in the same
cells (Fig. 4B, a and b). In contrast, in the U373-PML cell
line, both IE2 and PML were still colocalized or associ-
ated with PODs at 6 h (Fig. 4B, c and d). At 9 h, the IE2
distribution pattern became relatively normal in the
U373-PML cell line, including showing residual tiny
punctate spots within a relatively strong nuclear diffuse
background in approximately half of the cells (Fig. 4B, e
and f). These results indicate that the overexpression of
PML(560) significantly delays redistribution of PML by
FIG. 3. Loss of the overexpressed PML IFA signals in U373-PML
cells undergoing mitosis. U373-Neo cells (a, b, e, and f) or U373-PML
cells (c, d, g, and h) were fixed and permeabilized either by a parafor-
maldehyde/Triton X-100 procedure (a–d) or in methanol (e–h) and
double-label staining for both PML by rhodamine IFA and DNA by DAPI
was carried out. (a, c, e, and g) IFA of PML with rabbit anti-PML(C) PAb.
(b, d, f, and h) Staining of nuclei in the same fields with DAPI. Cells
undergoing mitosis, as judged by DNA staining of metaphase chromo-
some, are indicated with arrows (f and g).
than 10
s, inter
43ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONIE1. Because of this delay, colocalization of IE2 and PML
in punctate domains was readily detectable with wild-
type HCMV infection in U373-PML cells, whereas this
was not the case in the control U373-Neo cells.
Enhanced IE2 association with PODs in the absence
of IE1 in U373-PML cells
In wild-type HCMV(Towne) infection of HF cells, newly
synthesized IE2 displays a mixed punctate and nuclear
diffuse pattern beginning 2 to 4 h after infection (Ahn and
FIG. 4. Delayed disruption of PODs in U373-PML cells at early times
with HCMV(Towne) at an m.o.i. of 0.5. (A) Double-label IFA (methan
anti-PML(C) PAb at 4 h (a–d) and at 9 h (e and f). FITC-labeled donkey
visualization. (B) Double-label IFA was carried out with mouse anti-IE2
The numbers of cell showing each PML pattern (ND, ND/P, and P) amo
22 h in U373-PML cells (indicated as % bars). For this experiment, more
diffuse pattern (ND); open bars, nuclear punctate pattern (P); gray barHayward, 1997; Ahn et al., 1998). By using the IE1-deleted
virus HCMV(CR208) and confocal microscopy weshowed previously that these punctate IE2 domains con-
sist of a mixture of some sites that directly colocalize
with PML and other sites that are adjacent to or touch
PML-containing PODs. Although loss of SUMOylated
forms of PML also leads to loss of Sp100 and Daxx from
PODs (Maul et al., 2000), there must be some underlying
matrix-associated cellular structure that attracts PML
itself. Presumably, in wild-type herpes virus-infected
cells the IE110 and IE2 punctate domains represent
these same underlying residual matrix structures, de-
ild-type HCMV infection. U373-Neo and U373-PML cells were infected
edure) was carried out with mouse anti-IE1 MAb (6E1) and rabbit
use IgG and rhodamine-coupled donkey anti-rabbit IgG were used for
12E2) and rabbit anti-PML(C) PAb at 6 h (a–d) and at 9 h (e and f). (C)
-positive cells were counted at 4 h in U373-Neo cells and at 4, 9, and
0 total IE1-positive cells were scored on each slide. Solid bars, nuclear
mediate mixed pattern of both ND and P (ND/P).after w
ol proc
anti-mo
MAb (
ng IE1spite the disappearance of PML. Between 12 and 24 h
after either HCMV(Towne) infection or HCMV(CR208) in-
44 AHN AND HAYWARDfection in HF cells, the IE2 pattern changes to become
predominantly nuclear diffuse, and by 48 h IE2 becomes
efficiently colocalized with newly forming viral DNA rep-
lication compartments that are bounded by PODs (Ahn et
al., 1999). In the present investigation, IE2 was predom-
inantly punctate at 6 h after infection of both U373-Neo
and U373-PML cells and had changed to predominantly
nuclear diffuse with some punctate spots by 24 h (Figs.
5a and 5b). Similarly, in HCMV(CR208)-infected U373-
Neo cells, despite the fact that PML remained exclu-
sively in the PODs (not shown), IE2 had become mixed
nuclear diffuse and punctate by 24 h (Fig. 5c). However,
in dramatic contrast, in the circumstances of combined
DIE1 infection in U373-PML cells, IE2 now still remained
predominantly colocalized with enlarged PODs even as
late as 24 h after infection (Fig. 5d). (Note that the mag-
nification factor is reduced twofold in Fig. 5 compared to
Figs. 1 and 4.) Evidently, the altered structures of PODs in
PML(560)-overexpressing cells have a profound effect on
the localization of IE2, but the presence of IE1 (and the
consequent displacement of PML) normally overcomes
this effect in wild-type HCMV-infected cells.
Suppression of viral DNA replication compartment
formation in U373-PML cells
To study whether the delayed disruption of PODs also
affects aspects of viral DNA replication, we compared
the efficiency of formation of replication compartments
(R.C.) between U373-Neo and U373-PML cells after in-
fection with wild-type HCMV(Towne) or IE1-deleted HC-
MV(CR208). The 52-kDa viral polymerase processivity
FIG. 5. Comparison of the distribution patterns of IE2 in U373-Neo or
U373-PML cells after infection with wild-type or IE1-defective mutant
HCMV. U373-Neo (a and c) and U373-PML (b and d) cells were infected
at an m.o.i. of 1.0 with wild-type HCMV(Towne) (a and b) or with
IE1-defective mutant HCMV(CR208) (c and d). At 24 h, cells were fixed
in methanol and stained for IE2 as described in Fig. 4.factor protein encoded by UL44 is known to be useful as
a marker that is incorporated into the R.C., both at late
I
Utimes after virus infection (Ahn et al., 1999; Fortunato and
Spector, 1998; Iwayama et al., 1994; Penfold and Mocar-
ski, 1997; Sarisky and Hayward, 1996) and in transient
cotransfection assays (Sarisky and Hayward, 1996). In
addition, we showed that IE2 also accumulates in pre-
R.C. and R.C. beginning at 48 h after virus infection (Ahn
et al., 1999). Initially both U373-Neo and U373-PML cells
were infected with HCMV(Towne) at an m.o.i. of 0.5 and
fixed at 48 h followed by single-label IFA with MAb
against UL44. At this time point, among those U373-Neo
cells judged to be infected by the presence of positive
UL44 nuclear IFA signals, 30% showed formation of rel-
atively small early subnuclear R.C. (Fig. 6a), but only 5%
of the infected U373-PML cells showed similar R.C. (Fig.
6b). The results of UL44 staining at 24, 48, and 72 h with
HCMV(CR208) at an m.o.i. of 0.5 in both cell types are
also shown in Figs. 6c–6h. Although no R.C. formation
was detected at 24 h in either cell type, the number of
FIG. 6. Reduced formation of viral DNA replication compartments in
ild-type or IE1-defective mutant HCMV-infected U373-PML cells.
373-Neo and U373-PML cells were infected at an m.o.i. of 0.5 with
ild-type HCMV(Towne) for 48 h (a and b) or with the IE1-defective
utant HCMV(CR208) for 24 h (c and d), 48 h (e and f), and 72 h (g and
) before fixation. Photomicrographs show single-label IFA with mouse
Ab against UL44(p52) and FITC-labeled donkey anti-mouse IgG.w
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45ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONUL44-positive U373-PML cells appeared diminished
compared to the number of UL44-positive U373-Neo
cells. However, some R.C. had formed by 48 h in HCM-
V(CR208)-infected cells; by 72 h the number of R.C. was
relatively normal in U373-Neo cells and occasional R.C.
could also be detected even in HCMV(CR208)-infected
U373-PML cells. These results demonstrated that over-
expression of PML inhibited or delayed the efficient
formation of R.C. as well as the disruption of PODs.
Altered patterns of IE2 localization and R.C. formation
at high m.o.i. in U373-PML cells in the absence of IE1
Because most IE2 still remained associated with
PODs at 24 h in U373-PML cells after infection with
HCMV(CR208) at an m.o.i. of 1.0 (Fig. 5d), we investigated
whether IE2 localization and R.C. formation were also
still aberrant at a later time point (48 h) under high m.o.i.
conditions (5.0 PFU [plaque-forming units]/cell). In HCM-
V(Towne) infection, 50% of U373-Neo cells showed a
typical R.C. staining pattern for IE2 (Fig. 7a). Although
similar R.C. staining for IE2 was also observed at 48 h in
both HCMV(Towne)-infected U373-PML cells (Fig. 7b)
and HCMV(CR208)-infected U373-Neo cells (Fig. 7c), the
efficiency was reduced two- to threefold in both cases. In
contrast, most U373-PML cells infected with HCM-
V(CR208) at 48 h still displayed a punctate pattern, in
which IE2 remained associated with PODs (Fig. 7d). Less
than 10% of the cells here also showed larger R.C.-like
IE2 domains (Fig. 7d). Parallel examination of the num-
bers of cells with UL44-positive R.C. in the same exper-
iments (Figs. 7e–7h) again showed a similar reduction of
R.C. formation in U373-PML cells and in HCMV(CR208)-
infected cells, and confirmed that only the larger IE2-
positive domains, but not the numerous smaller punctate
IE2 spots observed in HCMV(CR208)-infected U373-PML
cells, corresponded to R.C. or pre-R.C. (Ahn et al., 1999).
The experiments described earlier did not address
hether the reduced R.C. formation also correlated with
educed UL44 expression or whether it might be an
ndependent effect unrelated to the levels of early pro-
eins synthesized. For a more quantitative assessment of
he effects on UL44 synthesis compared to actual R.C.
ormation, we carried out experiments to measure the
umber of IE2, UL44, and R.C.-positive cells detected by
FA at 48 h at an m.o.i. of either 0.2, 1.0, or 5.0 PFU per
ell. The results obtained are presented in Table 1 both
s direct percentages of cells in the culture that were
ositive for each antibody and as fractions of IE2-positive
nfected cells that also expressed UL44 (nuclear diffuse
orm) or that showed R.C. formation. At this time point,
he numbers of cells expressing IE2 were unaffected by
he presence of overexpressed PML or the absence of
E1, or both. However, the fraction of cells containing R.C.
mong IE2-positive cells in HCMV(Towne)-infected
373-PML cells at an m.o.i. of 1.0 was reduced nearlyfivefold, to 7% compared to 33% in U373-Neo cells, al-
though the fraction of cells expressing UL44 among
IE2-positive cells was also reduced 1.8-fold from 64 to
36%.
Somewhat surprisingly the lack of IE1 had a signifi-
cantly smaller inhibitory effect on R.C. formation than that
produced by PML overexpression. For example, the frac-
tion of cells showing R.C. formation among IE2-positive
cells was reduced only 2.4-fold, to 14% in HCMV(CR208)-
infected U373-Neo cells, at an m.o.i. of 1.0. There was
also only a small reduction (1.4-fold, from 64 to 46%) in
the fraction of UL44-positive cells here. Importantly, R.C.
formation in HCMV(CR208)-infected U373-PML cells at
the same m.o.i. was further reduced to only 3% of all
FIG. 7. Formation of viral DNA replication compartments in U373-Neo
or U373-PML cells after infection with wild-type or IE1-defective mutant
HCMV. U373-Neo (a, c, e, and g) and U373-PML (b, d, f, and h) cells
were infected at a high m.o.i. of 5.0 with wild-type HCMV(Towne) (a, b,
e, and f) or with the IE1-defective mutant HCMV(CR208) (c, d, g, and h).
At 48 h after infection, cells were fixed in methanol followed by single-
label IFA for IE2 and UL44(p52). (a–d) IE2 was stained as described in
Fig. 4. (e–h) UL44(p52) was stained with mouse MAb against UL44(p52)
and FITC-labeled donkey anti-mouse IgG.IE2-positive cells, representing an 11-fold reduction over
that of HCMV(Towne)-infected U373-Neo cells, whereas
UL44
ong IE
46 AHN AND HAYWARDthe reduction in UL44-positive cell here was only 2.6-fold.
Therefore, the use of HCMV(CR208) and U373-PML cells
individually reduced the number of UL44-positive cells
going on to R.C. formation by 48 h (2.3-fold and fivefold,
respectively), but the combined effects were additive,
producing an eightfold overall reduction.
In the experiment carried out at a higher m.o.i. of 5.0,
R.C. formation was also reduced sixfold overall to 11% in
HCMV(CR208)-infected U373-PML cells compared to
60% in HCMV(Towne)-infected U373-Neo cells, repre-
senting a combination of the effects obtained individually
by deleting IE1 and overexpressing PML, with UL44
expression levels showing only a modest 25% overall
reduction (from 90 to 67%). In contrast, in the parallel
experiment at a lower m.o.i. of 0.2, no R.C. formation was
detected at 48 h, even in HCMV(Towne)-infected U373-
Neo cells. However, the fraction of UL44-positive cells
compared to IE2-positive cells decreased twofold (from
60 to 27%) for both HCMV(Towne)-infected U373-PML
cells and HCMV(CR208)-infected U373-Neo cells, and
was reduced nearly eightfold (down to only 8%) for HC-
MV(CR208)-infected U373-PML cells. Therefore, the
combined effect of PML overexpression and the lack of
IE1 had a moderate negative effect (sixfold) on R.C.
formation, and little effect on UL44 expression at the
highest m.o.i., but instead gave an eightfold negative
effect on the number of IE2-positive cells that progress to
express UL44 at the lowest m.o.i. Overall, these results
demonstrate that both overexpression of PML and a lack
of IE1 independently inhibit the efficient formation of R.C.
as well as the disruption of PODs. They also suggest that
there is an effect on R.C. formation that is independent of
the reduced synthesis of early proteins (exemplified by
T
Relative Efficiency of R.C. Formation Detecte
Cell types Virus M.O.I.
IE2-positive
(%)
U373-Neo Towne 5.0 86
-PML Towne 5.0 80
U373-Neo CR208 5.0 90
-PML CR208 5.0 88
U373-Neo Towne 1.0 73
-PML Towne 1.0 74
U373-Neo CR208 1.0 80
-PML CR208 1.0 76
U373-Neo Towne 0.2 15
-PML Towne 0.2 15
U373-Neo CR208 0.2 22
-PML CR208 0.2 25
a At least 200 cells were counted over at least five representative ra
b Only cells showing 1 to 3 large granular intranuclear structures by
c Fraction of cells (%) expressing UL44 or showing R.C. formation amUL44), and which is not overcome by high m.o.i. effects
in U373 cells.Overexpression of PML suppresses the levels of both
early and late viral proteins during HCMV(Towne)
infection
Our IFA results with U373-Neo and U373-PML cell
lines showed that both the disruption of PODs and the
formation of viral R.C. were considerably delayed in U373
cells overexpressing PML(560) and that there were also
effects on viral early protein synthesis. Therefore, to
quantitatively examine the overall levels of specific viral
proteins produced, cells were harvested at 6, 24, 48, 72,
and 144 h after infection with wild-type HCMV and total
protein extracts were prepared. Equal amounts of the
electrophoretically separated protein extracts from U373-
Neo and U373-PML cells were subjected to Western
immunoblot analysis performed with MAbs against
IE1(UL123), the early replication protein p52(UL44), and a
late capsid protein pp28(UL99). Note that, of necessity
for biochemical analysis, these experiments could be
carried out only at relatively high m.o.i. (5.0 PFU/cell).
Photographs of the protein bands detected and quan-
titation of the band intensity by densitometry are shown
in Figs. 7a and 7b, respectively. The results revealed,
first, that the levels of IE1 (72 kDa) were slightly delayed
at 6 h and reduced less than twofold between 24 and
72 h in U373-PML cells compared to those in U373-Neo
cells, although they reached similar levels at 144 h (Fig.
8A, a and b; Fig. 8B, a). Second, a 3.5-fold reduction of
UL44 (52 kDa) levels occurred at 24 h in U373-PML cells
compared to U373-Neo cells, although the difference
was reduced to twofold at 48 and 72 h and they again
reached similar levels by 144 h (Fig. 8A, a and b; Fig. 8B,
A at 48 Hours after Infection of U373 Cellsa
UL44 positive cells R.C.-positive cellsb
% Fractionc % Fractionc
77 0.90 52 0.60
54 0.68 29 0.36
76 0.84 39 0.43
58 0.67 10 0.11
47 0.64 24 0.33
27 0.36 5 0.07
37 0.46 11 0.14
19 0.25 2 0.03
9 0.60 0 0
4 0.27 0 0
6 0.27 0 0
2 0.08 0 0
y-selected fields.
staining were counted.
2-positive cells (%).ABLE 1
d by IF
cells
ndomlb). The MAb against UL44 (52 kDa) used in this study
specifically detected two additional smaller bands mi-
i
t
b
u
a
p
a ML ce
b (Towne
47ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONgrating between 35 and 40 kDa (Fig. 8A, a and b, indi-
cated as p52*). These bands appeared to be alternative
versions of UL44 that are specifically expressed at the
late stages of infection. Interestingly, these bands were
even more depressed (.10-fold) to almost undetectable
levels at 48 and 72 h after infection in U373-PML cell
lines compared to the control cells (Fig. 8A, a and b; Fig.
FIG. 8. Suppression of viral protein synthesis levels at different tim
mmunoblots. Cells were infected with either the wild-type HCMV(Town
he equivalent of 1 3 104 cells of U373-Neo (a, c, e, and g) or U373-PML
lotting. Mixtures of either anti-IE1 MAb (6E1) and anti-UL44 MAb for p
sed to detect both viral proteins simultaneously. To detect the late vir
nd h). (B) Quantitative comparison of the levels of suppression of vira
rotein bands in the Western blot assay (A) were captured using an Alp
s relative density units. White bars, U373-Neo cells; black bars, U373-P
etween U373-Neo and U373-PML cells infected with wild-type HCMV8B, c), but reached nearly normal levels at 144 h. To
examine whether other true late proteins might also bemore suppressed than the early proteins in U373-PML
cell lines, we examined the levels of the minor capsid
protein UL99 (28 kDa). Again, pp28 levels were 22-fold
suppressed at 72 h and remained nearly threefold sup-
pressed in U373-PML cells even at 144 h after infection
(Fig. 8A, c and d; Fig. 8B, d). Overall, these results
demonstrated that, although the levels of viral IE and
r infection with wild-type or IE1-defective HCMV. (A) Photographs of
s (a–d) or HCMV(CR208) (e–h) at an m.o.i. of 5.0. Extracts derived from
f, and h) were fractionated by SDS–8% PAGE and subjected to Western
nd b) or anti-IE2 MAb (12E2) and anti-UL44 MAb for p52 (e and f) were
capsid antigen, anti-pp28 MAb was used on a separate blot (c, d, g,
ins. Images from XAR films after chemiluminescence detection of the
ger and the intensity of each protein band was measured and plotted
lls. The histograms show comparison of IE1, p52, p52*, and pp28 levels
) (a–d) or IE1-defective HCMV(CR208) (e–h).es afte
e) viru
(b, d,
52 (a a
al pp28
l prote
ha Imaearly proteins were only slightly and moderately delayed
or suppressed by overexpression of PML(560), the levels
48 AHN AND HAYWARDof late pp28 and p52* proteins were strongly depressed
even with wild-type HCMV infection at high m.o.i.
Viral protein levels in U373-Neo cells after infection
with IE1-defective HCMV(CR208)
HCMV(CR208) contains a deletion of the entire MIE
exon-4 segment of IE1 within the HCMV(Towne) back-
ground (Greaves and Mocarski, 1998). Although this mu-
tant virus is able to replicate relatively normally in HF cell
cultures under high m.o.i. conditions, it fails to give effi-
cient lytic cycle infection at low m.o.i. (Greaves and
Mocarski, 1998). Nevertheless, as we showed previously,
the DIE1 mutant virus fails to disrupt the PODs at both
low and high m.o.i. in infected HF cells (Ahn et al., 1998),
suggesting that something about high m.o.i. infection
can overcome or bypass the lack of disruption of PODs
by IE1.
Examination of the levels and time course of viral early
and late proteins produced by HCMV(CR208) infection in
the U373-Neo cell line revealed that the DIE1 virus gave
only slightly reduced p52 levels compared to those ob-
tained with wild-type virus in these cells at high m.o.i.
However, there was a fourfold inhibitory effect on the
p52* and pp28 protein levels at 48 h, but normal levels
were produced at 72 and 144 h (Fig. 8A, a, c, e, and g; Fig.
8B, c, d, g, and h). Therefore, just as in HF cells, the use
of high m.o.i. infection conditions needed for biochemical
analysis largely overcame any effects of the absence of
IE1 in the U373-Neo cells.
Infection with IE1-defective HCMV(CR208) leads to
severe suppression of late viral protein level in U373-
PML cells
We also investigated the effect of overexpressed
PML(560) on viral protein levels in HCMV(CR208)-in-
fected U373-PML cells compared to those in U373-Neo
cells. For HCMV(CR208) mutant virus-infected cells, the
levels of the 86-kDa IE2 (UL122) protein detected with
MAb 12E2 were used as a substitute for the previous IE1
measurements carried out with wild-type virus. However,
once again after infection of the U373-PML cell line with
HCMV(CR208) at an m.o.i. of 5.0, there was very little
effect on the protein levels of IE2 compared to those of
the U373-Neo cell line (Fig. 8A, e and f; Fig. 8B, e), except
that the amount of IE2 at 144 h was somewhat reduced
compared to that at 72 h in the U373-PML cells, resulting
in an overall twofold suppression of IE2 levels between
the two cell lines at this later time point (Fig. 8B, e). In
comparison, there was a sevenfold suppression of early
p52(UL44) protein levels at 24 h, although this was re-
duced to only a two- to threefold effect at the later time
points (Fig. 8A, e and f; Fig. 8B, f). Moreover, the late p52*
and pp28 proteins were almost undetectable at 72 h and
still gave a five- to 10-fold reduction at 144 h in theU373-PML cells compared to that in U373-Neo cells
(compare Fig. 8A, e and f, g and h; Fig. 8B, g and h).
When the levels for p52, p52*, and pp28 in the U373-
PML cell line were compared between HCMV(Towne)
and HCMV(CR208) infections, two- to threefold greater
suppression of both the viral early and late proteins was
observed in cells infected with IE1-deleted virus than
with wild-type virus (Fig. 8B). Therefore, overall these
results demonstrate that overexpression of PML(560)
has a somewhat greater inhibitory effect than the ab-
sence of IE1 at high m.o.i. and that the absence of
disruption of PODs by IE1 combined with overexpression
of PML(560) produces an additional effect on early pro-
tein levels and contributes to a very profound inhibition
of late viral protein levels.
Effects of PML overexpression on activation of the
UL54(Pol) or UL99(pp28) promoters
Recently, Ishov et al. (1997) have shown that initiation
of HCMV IE transcription occurs at the periphery of
PODs. To ask whether the reduced or delayed accumu-
lation of viral proteins during HCMV infection in the
presence of overexpressed PML(560) might be associ-
ated with lower transcription rates, we took advantage of
an existing luciferase (LUC) reporter system placed into
the context of the HCMV genome. Two recombinant
HCMV viruses expressing LUC reporter genes under the
control of either the HCMV UL54(Pol) early promoter or
the HCMV UL99(pp28) late promoter were generated by
insertion of the reporter genes between the US9 and
US10 ORFs in the wild-type HCMV(Towne) viral genome
(Burns, W. H. et al., in preparation). These extragenic
reporter genes display authentic early and late transcrip-
tional characteristics after infection of both HF and U373
cells, with Pol-LUC being expressed strongly within 24 h
and being minimally affected by PAA or GCV treatment,
whereas pp28-LUC expression is strongly activated only
at later times (48 or 72 h) and is inhibited 99% in the
presence of the DNA synthesis inhibitors (Burns, W. H. et
al., in preparation).
Both the U373-PML and control U373-Neo cell lines
described earlier were infected with HCMV(Pol-LUC) at
an m.o.i. of either 4 or 0.5 PFU/cell. Extracts were pre-
pared at 16, 40, and 64 h, and assayed for LUC activity.
The results showed that at both high and low m.o.i., LUC
levels were three- to fivefold lower in U373-PML cells
than in U373-Neo cells (Figs. 9A and 9B). A greater
reduction in LUC activity (4.5-fold) occurred in the U373-
PML cell line at a low m.o.i. infection than at a high m.o.i.
infection (2.7-fold) at 16 h. Similarly, infection of both cell
lines with HCMV(pp28-LUC) at an m.o.i. of 5.0 revealed
2.5- and fourfold reduced late gene transcription at 40
and 88 h, respectively, in the U373-PML cell line (Fig. 9C).
These results imply that the lower accumulation of early
and late viral proteins in cells overexpressing PML(560)
plicated
49ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONmay be related to lower rates of gene transcription,
which in turn could be related to lower functional activity
of the IE proteins or to inappropriate localization of either
IE2 or of the viral DNA templates themselves.
DISCUSSION
Role of the IE1 protein in HCMV infection and
permissiveness
Little is known at present about either the nature of
host cell permissiveness for HCMV or the role of the
abundant acidic nuclear protein IE1. In our experience,
only cultured diploid human fibroblasts, primary smooth
muscle cells, and IE1-expressing variants of the U373
astrocytoma cell lines produce plaques when infected
with wild-type HCMV(Towne), and primary endothelial
cells can do so only with certain clinical isolates (Jang,
W.-J., Lee, C.-H., Ahn, J.-H., and Hayward, G. S., unpub-
lished data). Two abundant nuclear proteins are ex-
pressed at very early times or under cycloheximide-
restricted IE conditions in HCMV-infected permissive HF
or U373 cells. The two proteins IE1 and IE2 are also the
only viral proteins known to be expressed at any stage
after infection in the class of nonpermissive cells, exem-
plified by rodent fibroblasts such as RAT-1 and NIH/3T3
cells (LaFemina and Hayward, 1988). All subsequent
HCMV gene expression is thought to be dependent on
the functional activity of IE2 acting as an essential tran-
scriptional transactivator that is evidently ineffective or
inoperative in rodent compared to human cells. The role
of the even more abundant IE1 protein, which is synthe-
sized first but is not essential in cultured HF cells in-
fected at high m.o.i., has remained unexplained. By most
FIG. 9. Activation of the UL54(Pol) promoter and the UL99(pp28) prom
infected with a recombinant virus, HCMV(Pol-LUC), containing the extra
of 0.5 (B) or with HCMV(pp28-LUC), containing the extragenic pp28-LU
extracts were prepared for LUC assays. Equal amounts of clarified extr
mock-infected cells are indicated. The results were averaged from ducriteria, IE1 is not a significant transcriptional transacti-
vator on its own, although it does synergize with IE2 insome cotransfection reporter gene assays involving cer-
tain late viral promoters. Our attention here has focused
on the only two known functional effects of IE1: (1)
displacing PML from the PODs and (2) enhancing the
efficiency of plaque formation and lytic cycle progression
at low m.o.i. in permissive HF cells. However, only the
former seems to be a direct effect, with the latter poten-
tially either depending on PML interactions or involving
some unknown mechanism to stimulate the activity of
another viral protein, most likely IE2.
We hypothesized that by overexpressing PML in a cell
line in which the HCMV lytic cycle is both slower and
more sensitive to m.o.i. effects than are HF cells, we
might be able to generate a similar effect to that of
inactivating IE1. The results of either PML overexpres-
sion or the use of an IE1-deleted virus proved to be
reduced levels of accumulation of several tested early
and late viral proteins, even at a high m.o.i. of 5 PFU per
cell and overall slower progression of the whole lytic
cycle. Furthermore, the deficiencies were compounded
when infection was carried out with the DIE1 virus in the
PML(560)-overexpressing cells. In fact, the levels of late
proteins present at 144 h under these conditions were
still several-fold lower than those present at 48 h with
wild-type virus in the control U373-Neo cell line. Reduced
or slowed viral gene expression was manifested at each
of three levels examined: (1) the efficiency of early and
late transcription as measured with LUC reporter genes
inserted into the viral genome; (2) the total steady-state
amounts of viral early and late proteins produced; and (3)
the formation of early viral DNA replication compart-
ments detectable by IFA. These effects correlated with
reduced or abolished PML dispersal from PODs and with
HCMV-infected U373 cell lines. U373-Neo and U373-PML cells were
ol-LUC fusion reporter gene at a high m.o.i. of 5.0 (A) and at a low m.o.i.
n reporter gene at an m.o.i. of 5.0 (C). At the indicated time points, cell
ere used for each assay and fold increases compared to extracts from
dishes.oter in
genic P
C fusio
acts wgreatly enhanced accumulation of IE2 either in or adja-
cent to PODs.
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50 AHN AND HAYWARDPOD disruption and HCMV lytic cycle progression
Stable overexpression of PML(560) in our U373 cell
line had little effect on cell growth rates, the proportion of
cells in the cell cycle, or the fraction of apoptotic cells
compared to a control NeoR cell line generated in paral-
lel. Perhaps because U373 cells contain high levels of
mutant p53 protein, they may be less likely to be apo-
ptotic in response to overexpressed PML or to show the
phenotypes reported for several PML-overexpressing
cell types described by others. The PML(560) protein is
the smaller of the two predominant differentially spliced
forms of PML (68 and 110 kDa) that differ in relative
abundance in different cell types, but presumably the
110-kDa and other minor isoforms of PML are still ex-
pressed at normal levels. In addition, the exogenous
PML(560) gene in our overexpressing cell line, although
producing a PML protein product of the correct expected
molecular weight, may have acquired a loss of function
mutation. Considering that the few rare stable IE2-ex-
pressing cell lines known all contain mutations, and that
this particular clone was the only one of 20 examined
receiving the coselected PML gene that produced sig-
nificantly enlarged PODs, this latter scenario appears
plausible and is under investigation. However, for our
purposes here, the functionality or other characteristics
of the exogenous PML protein product was of only sec-
ondary relevance, especially since it is not known
whether the active state of wild-type PML occurs when
aggregated in the PODs or when dispersed. The use of
the viral MIE promoter/enhancer to drive PML was a
deliberate part of our experimental design. Concerns
that the overexpressed PML(560) protein might be sub-
jected to IE2 downregulation were counterbalanced by
the greater likelihood that the HCMV virion factor UL82
might instead lead to initial upregulation of exogenous
PML after infection, as occurs for the virus-encoded IE1
and IE2 genes themselves. Indeed, the soluble PML(560)
level in U373-PML cells was slightly upregulated (less
than twofold) as measured by Western immunoblot anal-
ysis at 48 h after viral infection (data not shown). Fur-
thermore, we wished to express PML under the control
of the strongest promoter available and we intended that
the U373-PML cell line should provide a parallel reagent
to those of our set of U373-IE1/IE2-expressing cell lines,
which are also driven by the MIE enhancer.
Despite the unusually large PODs, they disappeared
normally in mitotic U373-PML cells, but evidently infec-
tion with wild-type HCMV did not produce sufficient IE1
to displace PML and most of the IE1 protein was itself
also retained in the PODs for much longer than usual.
Apparently this then leads to a block or delay in synthe-
sis of downstream viral gene products. These results are
consistent with the notion that the principal role of IE1 is
to increase the efficiency of initiation of the lytic cycle,
especially under the low m.o.i. conditions that presum-
c
gably pertain in vivo, and that this function involves the
interactions of IE1 with PML and the PODs. However, we
cannot ascertain as yet whether the enhancing effect is
a general one, acting directly at several different levels
associated with POD interactions, or is a more specific
one, perhaps involving just effects on IE2 localization
and function, which may constitute a rate-limiting step for
subsequent lytic cycle events. Considering that PML was
eventually dispersed from all HCMV(Towne)-infected
U373-PML cells by 22 h (Fig. 4C) and that all HCM-
V(CR208)-infected U373-PML cells showed dramatically
enhanced IE2 localization in POD-like domains at 48 h
(Fig. 7d), we favor the model that all cells are delayed in
the progression of the lytic cycle but can eventually
recover, rather than that just a few cells overcome some
threshold, while the rest are rendered nonpermissive.
Although an original HCMV(DIE1) mutant studied by
Mocarski et al. (1996), referred to as RC303DAcc, dis-
layed greatly reduced IE2 expression at low m.o.i., the
CMV(CR208) mutant used here instead gave relatively
ormal levels of IE2 even at low m.o.i., but was greatly
eficient in both UL44 expression and R.C. formation and
ormed only microplaques with 1000-fold reduced titer
ompared to wild-type HCMV(Towne) in HF cells at low
.o.i. (Greaves and Mocarski, 1998). These results were
nterpreted to indicate not only a requirement for multiple
it kinetics to establish a productive infection but also
vidence for a direct impact of IE1 on UL44 expression
hat occurs independently of IE2 (Greaves and Mocarski,
998). Our results with HCMV(CR208) gene expression in
373 cells are similar to those described in HF cells,
ncluding being totally deficient in displacement of PML
rom the PODs, but they also show directly both deficien-
ies in expression of other viral proteins besides UL44
e.g., the late class pp28 protein) and suppressive effects
ccurring at the transcriptional level on both early and
ate viral promoters driving LUC reporter genes that are
arried in the viral genome.
The delays in gene expression under the conditions of
ombined PML overexpression and the absence of IE1
ppear to be significantly more than additive, but we do
ot consider it possible at present to interpret whether
he deficiencies involve the same or different mecha-
isms or to predict whether IE1 has other roles besides
hat of displacing PML. Importantly, our experiments do
ot provide evidence for any overall reduction in IE2
rotein levels under the circumstances of either PML
verexpression or the absence of IE1. However, the in-
racellular localization pattern of IE2 was changed dra-
atically, displaying greatly enhanced POD colocaliza-
ion during the early stages of infection (see Fig. 5).
lthough it could just be symptomatic of the retention of
ML in the PODs, this raises the possibility that de-
reased availability or functionality or inappropriate tar-
eting of IE2 could explain all of the other downstream
v
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transcription and formation of replication compartments.
Here we emphasize that the repressive effects on
HCMV lytic cycle progress obtained with both the DIE1
irus and the PML(560)-overexpressing cell line are the
xact opposite effects to those obtained with a set of
373-NeoR cell lines that constitutively express IE1. In
four of four cases tested, the latter cell lines already
display complete displacement of both PML and IE1 into
a nuclear diffuse form in 99% of the cells before infection
is initiated (Ahn and Hayward, 1997). Furthermore, all of
these lines show variable levels of enhancement of the
progression of even wild-type HCMV(Towne) lytic cycle
infection, as measured by greatly increased Pol-LUC and
pp28-LUC levels from our HCMV(Towne) reporter vi-
ruses, by increased progeny virus yields at much earlier
times, and, in at least two cell lines, by acquisition of the
ability to form plaques with HCMV(Towne) (Burns W. H. et
al., in preparation).
Therefore, in each of these situations, whether involv-
ing enhancement of the lytic cycle by constitutive expres-
sion of IE1, or depression of the lytic cycle by overex-
pression of PML and by deletion of IE1 from the viral
genome, there is a correlation with the timing and extent
of PML displacement that is consistent with this being a
rate-limiting, but not essential, function of IE1 that in-
creases the efficiency of initiation events for the viral lytic
cycle in the nucleus.
Significance of PML and POD interactions in DNA
virus infection
Several families of DNA viruses, including adenovirus
and herpesviruses, express very early virus-encoded nu-
clear proteins that target to and disrupt the punctate
intranuclear bodies known as PODs. Disruption of the
PODs is usually denoted by a loss of the IFA signal for
PML, the best-studied POD protein, although several
other POD proteins including SP100 are also displaced.
This effect superficially parallels the loss of PML from
PODs that occurs in association with the PML-RARa
translocation in most acute promyelocytic leukemia tu-
mor cells, a process that can be phenotypical and func-
tionally reversed by treatment with RA or arsenic trioxide.
In both HSV and HCMV, PML displacement occurs within
the first few hours of the initiation of infection, and one or
more viral-encoded proteins rapidly replace PML and
SP100 in punctate structures that appear to reside at the
same loci originally occupied by these cellular proteins.
The role of PML and the PODs in the cell is not yet fully
understood. PODs are believed to be dynamic structures
that naturally disaggregate during mitosis, but can be
increased in size and number in response to various
stimuli, including interferons and steroid hormones. In
the case of interferon, PML itself has a b-interferon-
responsive promoter that is inducible at the transcrip-tional level and appears to play some unknown role in
establishing the antiviral state for the RNA virus VSV
(Chelbi-Alix et al., 1998). Herpesviruses are not subject to
this type of antiviral state, although treatment with b-in-
terferon would probably mimic the effect that we ob-
tained here with overexpressed PML. However, PML has
also been claimed to be a tumor suppressor, to be
proapoptotic and antiproliferative, to induce G1 arrest
and to block HLA Class I presentation (Koken et al., 1995;
Le et al., 1998; Liu et al., 1995; Mu et al., 1994, 1997;
uignon et al., 1998; Wang et al., 1998a,b; Zheng et al.,
1998).
The mechanism of PML displacement from the PODs
appears to be very different in HSV and HCMV. Expres-
sion of either the HSV-encoded IE110 or IE68 proteins
can independently lead to displacement of PML, al-
though only IE110 is itself targeted to PODs. Like PML,
IE110 has a RING-finger class N-terminal domain and
this is essential for PML displacement but not for target-
ing to the PODs. Both HSV and IE110-mediated displace-
ment lead to degradation of SUMO-modified forms of
PML (Muller and Dejean, 1999) and this process is
blocked by inhibitors of 26S proteosomes, which also
disrupt progression of the HSV lytic cycle (Everett et al.,
1998). However, the displacement of PML from PODs by
HCMV utilizes a very different mechanism in which the
IE1 protein appears to physically interact with PML, pre-
sumably leading to prevention or disaggregation of POD
protein complexes and subsequent release of or accu-
mulation of both proteins in the nucleoplasm. Impor-
tantly, neither the unmodified nor the SUMO-modified
forms of PML are degraded by HCMV infection and the
IFA signal for SUMO also accumulates in a uniform
diffuse pattern in the nucleoplasm in HCMV-infected
cells (Xu, Y., Ahn, J.-H., and Hayward, G. S. unpublished
data). Furthermore, unlike the situation with HSV IE110,
displacement of PML by HCMV is not blocked by pro-
teosome inhibitors (Xu, Y., Ahn, J.-H., and Hayward, G. S.
unpublished data). The commonality here may be that,
subsequently, both HSV IE110 and HCMV IE2 accumu-
late at the original punctate loci previously occupied by
PML. Both of these proteins have strong nonspecific
transcriptional transactivator properties, but IE2 is also a
specific DNA-binding repressor, whereas IE110 also tar-
gets to an additional set of punctate nuclear loci repre-
senting centromeres, with an accompanying degradation
of the CENP-C protein, also by a proteosome-dependent
mechanism (Everett et al., 1999).
Perhaps significantly, RING-finger mutations in IE110,
which result in stable association of IE110 with PML in
the PODs, also completely abolish the transactivation
properties of IE110. Because SP100, which is also dis-
placed from PODs by both IE110 and IE1, is apparently
part of a transcriptional repressor complex with the
HMG2 and HP1 proteins (Lehming et al., 1998; Seeler et
al., 1998), we favor the idea that POD proteins play roles
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52 AHN AND HAYWARDin chromatin tertiary remodeling and that this is regu-
lated by proteosome-mediated protein stability, SUMO
and ubiquitin modifications, and nuclear and cytoplasmic
shuttling. Recent findings show (1) that, in addition to
PML and Sp100 (Kamitani et al., 1998; Muller et al., 1998;
ternsdorf et al., 1997), both IE1 and IE2 undergo SUMO
odification (Hofmann et al., 2000; Ahn, J.-H., Xu, Y., and
ayward, G. S., unpublished data); (2) that IE110 binds to
he HAUSP ubiquitin-conjugating enzyme and promotes
egradation of SUMO-modified PML (Everett et al., 1997,
998); and (3) that HCMV IE2 binds to both SUMO and
he UBC9-conjugating enzyme in yeast two-hybrid as-
ays (Ahn, J.-H., Jang, W.-J., and Hayward, G. S., unpub-
ished data). These observations all point to major, but as
et undefined, roles of these viral IE genes in protein
argeting and SUMO or proteosome-mediated pro-
esses, but whether the HCMV proteins are merely
hemselves subject to regulation by these processes or,
nstead, like IE110, act as viral regulators of the cellular
rocesses, remains to be determined.
MATERIALS AND METHODS
ell cultures
HF cells and U373 astrocytoma/glioblastoma cells
ere grown in Dulbecco’s modified Eagle’s medium sup-
lemented with 10% fetal calf serum. For maintenance of
he Neo-selected cell lines (U373-Neo and U373-PML),
00 mg/ml of G418 was added to the medium. To syn-
hronize cells at the G0 stage, 100% confluent cells were
aintained in medium with 0.5% serum for 3 days. To
elease from G0 block, synchronized cells were
rypsinized and replated onto chamber slides with fresh
ormal medium.
irus infection
The IE1-defective mutant virus HCMV(CR208)
Greaves and Mocarski, 1998) and its parent wild-type
CMV(Towne) virus were provided by Edward S. Mocar-
ki (Stanford University, Stanford, CA). The virus stocks
sed were prepared as described by LaFemina et al.
1989) and grown and titered in HF cells for HCMV-
Towne) or IE1-complementing ihfie1.3 cells (Greaves
nd Mocarski, 1998) for HCMV(CR208). For experiments
sing indirect immunofluorescence assays (IFA), cells
ere seeded into four-well chamber slides (0.6 3 105/
well), and the subconfluent cells were infected with HC-
MV(Towne) or HCMV(CR208) at various PFU per cell. For
Western blot analysis, cells were seeded into six-well
plates (2 3 105/well). Next day, cells were mock-infected
or infected with either HCMV(Towne) or HCMV(CR208) at
an m.o.i. of 5.0. For luciferase assays, cells were seeded
into 24-well plates (1 3 105/well), and next day cells were
nfected with recombinant HCMV(Pol-LUC) or HCM-
(pp28-LUC) virus. These recombinant viruses express
t
oxogenous luciferase (LUC) reporter genes under the
ontrol of the HCMV early UL54(Pol) promoter or late
L99(pp28) promoters and inserted between the US10
nd US11 divergent transcription unit (Burns, W. H. et al.,
n preparation). In all cases input supernatant virus was
iluted with serum-free medium and was adsorbed for
.5 h at 37°C, and then the inoculum was replaced with
resh warmed medium at time zero.
table selection of U373 cells
To generate U373-Neo and U373-PML, monolayer cul-
ures of the parental U373-MG cell line (American Tissue
ulture Collection, Rockville, MD) were transfected with
ither 0.25 mg of plasmid pSV2-Neo or 0.25 mg of pSV2-
Neo plus 5 mg of plasmid pCMX-PML (Kakizuka et al.,
1991), expressing an intact human PML cDNA (560 aa)
isoform provided by Ronald M. Evans (The Salk Institute,
San Diego, CA) by a modified calcium phosphate precip-
itation procedure described previously (Pizzorno and
Hayward, 1990). After 3 days, the cells were replated into
100-mm dishes and grown in the presence of 400 mg/ml
f G418. Neo-resistant colonies were recovered and an-
lyzed for the overexpression of PML by IFA and Western
lot analysis.
poptosis assay
To assay for externalization of the membrane phos-
holipid phosphatidylserine (PS) in apoptotic cells, cells
ere double-labeled with fluorescein-conjugated An-
exin V (Annexin V-FITC) and propidium iodide (PI). The
ells undergoing apoptosis that stain positive for An-
exin V-FITC and negative for PI were counted by ana-
ytical flow cytometry. The cells were washed twice with
old phosphate-buffered saline (PBS) and then resus-
ended in 13 binding buffer (10 mM HEPES/NaOH, pH
.4, 140 mM NaCl, 2.5 mM CaCl2) at a concentration of
3 106 cells/ml. Cells (1 3 105, 0.1 ml) were incubated
ith 5 ml of Annexin V-FITC (PharMingen, San Diego, CA)
and 5 mg/ml of PI for 30 min at 20°C in the dark. After
ddition of 0.4 ml of 13 binding buffer to each reaction,
ells were analyzed by flow cytometry within 1 h.
ntibodies and IFA
Mouse monoclonal antibodies (MAbs) 6E1 and 12E2
gainst HCMV IE1(UL123, exon-4) and IE2(UL122, exon-
), respectively, were obtained from Vancouver Biotech
Vancouver, B.C., Canada), and MAbs against UL44(p52)
nd UL99(pp28) were obtained from Advanced Biotech
Gaithersburg, MD). Rabbit antipeptide polyclonal anti-
ody (PAb)-referred anti-PML(C), directed against amino
cids at positions 484 to 498 of PML, was described
reviously (Ahn et al., 1998). For IFA, virus-infected cells
ere fixed and permeabilized by either the methanol orhe paraformaldehyde procedures as described previ-
usly (Ahn et al., 1998). The cells were incubated with
e
(
A
C
D
53ROLE OF POD DISRUPTION IN HCMV GENE EXPRESSIONeither MAbs at a 1:200-fold dilution or PAb for PML at a
1:1000-fold dilution in Tris-buffered saline (TBS) at 37°C
for 1 h, followed by incubation with fluorescence isothio-
cyanate (FITC)-labeled donkey anti-mouse immunoglob-
ulin G (IgG) or with rhodamine-coupled donkey anti-
rabbit IgG antibody at 1:100-fold dilution at 37°C for 45
min. For double-labeling, monoclonal and polyclonal an-
tibodies were incubated together. For DNA labeling,
mounting solution containing DAPI (Vector Laboratories,
Burlingame, CA) was used. Slides were screened and
photographed on a Leitz Dialux 20EB epifluorescence
microscope with Image-pro software (Media Cybernet-
ics, Silver Spring, MD).
For BrdU labeling, the cells were pulse-labeled with 10
mM bromodeoxyuridine (BrdU) for 30 min at 37°C and
were fixed and permeabilized as described earlier. The
cells were then treated with 4 N HCl for 10 min at 20°C
to expose the incorporated BrdU residues and washed
three times for 5 min each with PBS to neutralize the acid
before incubation with mouse anti-BrdU MAb (Becton
Dickinson).
Western blot analysis
Cells were washed with PBS and lysed with 0.2 ml of
ice-cold lysis buffer (50 mM Tris–HCl [pH 8.0], 150 mM
NaCl, 1.0% Nonidet-P40, 0.5% sodium deoxycholate, 0.1%
sodium dodecyl sulfate [SDS]). Clarified cell extracts
from the equivalent of 1 3 104 cells were separated on
SDS–8% polyacrylamide gels (PAGE) followed by elec-
troblotting onto nitrocellulose. The blots were blocked by
incubation for 1 h at room temperature in PBS plus 0.1%
Tween 20 containing 5% nonfat dry milk. The blots were
then washed twice with PBS–Tween 20 for 15 min and
incubated with appropriate MAb(s) at a dilution of
1:3000-fold for 1 h at room temperature. After three 10-
min washes with PBS–Tween 20, the blots were incu-
bated with horseradish peroxidase-conjugated goat anti-
mouse IgG (Bio-Rad, Hercules, CA) for 1 h at 20°C. The
blots were washed three times, and reacting protein
bands were detected with an enhanced chemilumines-
cence system (Amersham ECL RP2106) using Kodak XAR
film. For quantitation of the protein bands, XAR films were
scanned with an Alpha Imager (Alpha Innotech, San
Leandro, CA) using spot densitometry software program
and the relative amount of protein in each band was
described in density units.
Luciferase assay
Virus-infected cells were lyzed directly in 24-well
plates by a freeze–thaw disruption repeated three times
in 100 ml of 0.25 M Tris–HCl (pH 7.9) plus 1 mM DTT. The
extracts were clarified in a microcentrifuge and 50 ml of
xtracts were incubated with 300 ml of reaction buffer A
25 mM glycyl-glycine [pH 7.8], 15 mM MgSO4, 5 mM ATP,
and 4 mM EGTA) and then mixed with 100 ml of reactionbuffer B containing 1 mM luciferin (Sigma, St. Louis, MO)
at 20°C in the chamber of a LUMAT LB 9501 luminometer
using a 5-s assay of the photons produced (measured in
relative light units [RLU]).
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